Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 14, 2006; 12(6): 945-950
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.945
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.945
Regimen A(CIFN+zinc) | RegimenB (CIFN) | P | |
ALT (U/l): | |||
Wk 0 | 113±75 | 101±96 | NS |
Wk 24 | 46±51 | 40±30 | NS |
Wk 48 | 26±17 | 22±12 | NS |
Biochemical response (by intention to treat): | |||
Wk 24 (EBR) | 46% | 50% | NS |
Wk 48 (SBR) | 68% | 69% | NS |
Virological response (by intention to treat): | |||
Wk 24 (EVR) | 68% | 76% | NS |
Wk 48 (SVR) | 54% | 67% | NS |
- Citation: Suzuki H, Sato K, Takagi H, Kanda D, Sohara N, Kakizaki S, Nakajima H, Otsuka T, Nagamine T, Mori M. Randomized controlled trial of consensus interferon with or without zinc for chronic hepatitis C patients with genotype 2. World J Gastroenterol 2006; 12(6): 945-950
- URL: https://www.wjgnet.com/1007-9327/full/v12/i6/945.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i6.945